Michael Demurjian

Director Ejecutivo en Aspargo Laboratories, Inc. .

60 años

Health Technology

Consumer Services

Producer Manufacturing

Cargos activos de Michael Demurjian

Empresas	Cargo	Inicio	Fin
Tyme, Inc. Tyme, Inc. BiotechnologyHealth Technology Part of Syros Pharmaceuticals, Inc., Tyme, Inc. is a company that provides research and development services focused on developing drug candidates for the treatment of cancer. The company is based in Wilmington, DE. Steve Hoffman has been the CEO of the company since 2013. Tyme was acquired by Tyme Technologies, Inc., part of Syros Pharmaceuticals, Inc. from September 19, 2022 on March 05, 2015.	Director de Operaciones	-	-
Aspargo Laboratories, Inc. Aspargo Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Aspargo Laboratories, Inc. is a clinical stage pharmaceutical company, which focuses on developing an oral spray formulation of sildenafil. Its products include Sildenafil Oral Spray, an oral liquid suspension of sildenafil citrate administered via a spray pump that dispenses 12.5 mg of sildenafil per push of the pump or via an individual single liquid unit dispensing 100 mg per unit. The company was founded in 2019 and is headquartered in Englewood Cliffs, NJ.	Director Ejecutivo	-	-
	Presidente	-	-

Historial de carrera de Michael Demurjian

Antiguos cargos conocidos de Michael Demurjian.

Empresas	Cargo	Inicio	Fin
TYME TECHNOLOGIES, INC.	Director/Miembro de la Junta	01/04/2015	15/03/2019
	Director de Operaciones	01/04/2015	15/03/2019
	Director Financiero/CFO	01/04/2015	15/05/2015
	Fundador	22/11/2011	15/03/2019
Mikronite Technologies Group, Inc. Mikronite Technologies Group, Inc. Auto Parts: OEMProducer Manufacturing Mikronite Technologies Group, Inc. provides material surfacing technologies. The company was founded by Michael Demurjian and Steve Hoffman and is headquartered in Eatontown, NJ.	Fundador	01/01/1993	01/01/2007
	Ventas & Marketing	01/01/1993	01/01/2007
Luminant Biosciences LLC	Fundador	01/09/2011	-
Luminant Biosciences LLC	Corporate Officer/Principal	01/09/2011	-

Formación de Michael Demurjian.

New York University

Undergraduate Degree

Estadísticas

Internacional

Estados Unidos

Operativa

Founder	3
Chief Operating Officer	2
Director/Board Member	1

Sectorial

Health Technology	4
Consumer Services	2
Producer Manufacturing	2

Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Empresas relacionadas

Empresas privadas	5
Tyme Technologies, Inc. Tyme Technologies, Inc. Pharmaceuticals: MajorHealth Technology Tyme Technologies, Inc. operates as a biotechnology company, which engages in the development and commercialization of cancer therapies. It offers a clinical program named SM-88 which is a novel, oral, and monotherapy investigational agent that aims to disrupt the cancer cell's protein synthesis. The company was founded by Steve Hoffman and Michael Demurjian on November 22, 2011 and is headquartered in Bedminster, NJ.	Health Technology
Mikronite Technologies Group, Inc. Mikronite Technologies Group, Inc. Auto Parts: OEMProducer Manufacturing Mikronite Technologies Group, Inc. provides material surfacing technologies. The company was founded by Michael Demurjian and Steve Hoffman and is headquartered in Eatontown, NJ.	Producer Manufacturing
Tyme, Inc. Tyme, Inc. BiotechnologyHealth Technology Part of Syros Pharmaceuticals, Inc., Tyme, Inc. is a company that provides research and development services focused on developing drug candidates for the treatment of cancer. The company is based in Wilmington, DE. Steve Hoffman has been the CEO of the company since 2013. Tyme was acquired by Tyme Technologies, Inc., part of Syros Pharmaceuticals, Inc. from September 19, 2022 on March 05, 2015.	Health Technology
Luminant Biosciences LLC
Aspargo Laboratories, Inc. Aspargo Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Aspargo Laboratories, Inc. is a clinical stage pharmaceutical company, which focuses on developing an oral spray formulation of sildenafil. Its products include Sildenafil Oral Spray, an oral liquid suspension of sildenafil citrate administered via a spray pump that dispenses 12.5 mg of sildenafil per push of the pump or via an individual single liquid unit dispensing 100 mg per unit. The company was founded in 2019 and is headquartered in Englewood Cliffs, NJ.	Health Technology

Ver las conexiones de la empresa